Man Group plc: CYTK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Man Group plc on CYTK, newest first. How the timeline and the estimate are built.
Man Group plc held 17,393 CYTK shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 17,393 sharesChange vs previous 13F +6,930 shares
<0.01% of the 13F portfolio, value $1,481,709.
13F-HR 0001637460-26-000003 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 10,463 sharesChange vs previous 13F -1,124 shares
<0.01% of the 13F portfolio, value $689,616.
13F-HR 0001637460-26-000002 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 11,587 sharesChange vs previous 13F +11,587 shares
<0.01% of the 13F portfolio, value $736,238.
13F-HR 0001637460-26-000001 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -63,696 shares
13F-HR 0001085146-25-003321 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 63,696 sharesChange vs previous 13F -238,517 shares
0.01% of the 13F portfolio, value $2,996,260.
13F-HR 0001085146-25-001694 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 302,213 sharesChange vs previous 13F not available
0.05% of the 13F portfolio, value $15,956,848.
13F-HR 0001085146-24-005932 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).